174 related articles for article (PubMed ID: 23171359)
1. A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.
Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Yang K; Zhou J; Shen R; Zhang X; Shao Y
Viral Immunol; 2012 Dec; 25(6):477-84. PubMed ID: 23171359
[TBL] [Abstract][Full Text] [Related]
2. A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.
Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Liang H; Zhou J; Shen R; Zhang X; Shao Y
Arch Virol; 2011 Aug; 156(8):1455-62. PubMed ID: 21499906
[TBL] [Abstract][Full Text] [Related]
3. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.
Tagmyer TL; Craigo JK; Cook SJ; Even DL; Issel CJ; Montelaro RC
J Virol; 2008 Apr; 82(8):4052-63. PubMed ID: 18234792
[TBL] [Abstract][Full Text] [Related]
4. [The difference in specific humoral immune responses induced with the attenuated equine infectious anemia vaccine strain and virulent strain.].
Zhu ZY; Lin YZ; Wang YH; Zhao LP; Zhu YM; Zhou JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Dec; 25(12):1079-83. PubMed ID: 19961789
[TBL] [Abstract][Full Text] [Related]
5. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
[TBL] [Abstract][Full Text] [Related]
6. Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.
Mealey RH; Leib SR; Littke MH; Wagner B; Horohov DW; McGuire TC
Vaccine; 2009 Apr; 27(18):2453-68. PubMed ID: 19368787
[TBL] [Abstract][Full Text] [Related]
7.
Lin Y; Wang XF; Wang Y; Du C; Ren H; Liu C; Zhu D; Chen J; Na L; Liu D; Yang Z; Wang X
Emerg Microbes Infect; 2020 Dec; 9(1):1309-1320. PubMed ID: 32525460
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
Hammond SA; Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.
Craigo JK; Ezzelarab C; Cook SJ; Liu C; Horohov D; Issel CJ; Montelaro RC
PLoS Pathog; 2015 Jan; 11(1):e1004610. PubMed ID: 25569288
[TBL] [Abstract][Full Text] [Related]
10. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.
Tagmyer TL; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
J Gen Virol; 2007 Apr; 88(Pt 4):1324-1336. PubMed ID: 17374779
[TBL] [Abstract][Full Text] [Related]
11. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
Jin S; Issel CJ; Montelaro RC
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1120-9. PubMed ID: 15539516
[TBL] [Abstract][Full Text] [Related]
12. [Study of the correlation between the plasma viral load and protective immunity induced by the equine infectious anemia attenuated vaccine and its parental virulent strain].
Cao XZ; Lin YZ; Li L; Jiang CG; Zhao LP; Lv XL; Zhou JH
Bing Du Xue Bao; 2010 Mar; 26(2):128-33. PubMed ID: 20480642
[TBL] [Abstract][Full Text] [Related]
13. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
[TBL] [Abstract][Full Text] [Related]
14. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
[TBL] [Abstract][Full Text] [Related]
15. Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV).
Zhou W; Cook RF; Cook SJ; Hammond SA; Rushlow K; Ghabrial NN; Berger SL; Montelaro RC; Issel CJ
Vet Microbiol; 2002 Aug; 88(2):127-51. PubMed ID: 12135633
[TBL] [Abstract][Full Text] [Related]
16. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.
Craigo JK; Durkin S; Sturgeon TJ; Tagmyer T; Cook SJ; Issel CJ; Montelaro RC
Vaccine; 2007 Jan; 25(5):834-45. PubMed ID: 17023099
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression.
Zhang X; Wang Y; Liang H; Wei L; Xiang W; Shen R; Shao Y
J Gen Virol; 2007 Mar; 88(Pt 3):998-1004. PubMed ID: 17325374
[TBL] [Abstract][Full Text] [Related]
18. Envelope determinants of equine lentiviral vaccine protection.
Craigo JK; Ezzelarab C; Cook SJ; Chong L; Horohov D; Issel CJ; Montelaro RC
PLoS One; 2013; 8(6):e66093. PubMed ID: 23785473
[TBL] [Abstract][Full Text] [Related]
19. [Induction of EIAV-specific cellular immune response by attenuated EIAV vaccine].
Zhang XY; Li HM; Liang H; Shen T; Ma Y; Xiang WH; Shen RX; Shao YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):115-8. PubMed ID: 16388761
[TBL] [Abstract][Full Text] [Related]
20. Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine.
Liu L; Wan Y; Wu L; Sun J; Li H; Li H; Ma L; Shao Y
Retrovirology; 2010 Sep; 7():71. PubMed ID: 20807451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
